Corneal Edema clinical trials

Explore recruiting corneal edema clinical trials.

Recruiting corneal edema studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Corneal Edema trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Double-Masked, Randomized, Placebo-Controlled, Parallel-Group, 12-Week Administration With Two-Week Gradual Dose Taper Phase and 38-Week Follow-Up Phase, Phase 3 Study to Investigate the Safety and Efficacy of Ripasudil (K-321) Eye Drops After Descemetorhexis in Subjects with Fuchs Endothelial Corneal Dystrophy

Denmark, Spain, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Corneal Edema trials by city

Corneal Edema in Toronto Corneal Edema in Vancouver Corneal Edema in Montreal Corneal Edema in Calgary Corneal Edema in Edmonton Corneal Edema in Ottawa Corneal Edema in Winnipeg Corneal Edema in Quebec City Corneal Edema in Hamilton Corneal Edema in Kitchener Corneal Edema in London Corneal Edema in Halifax Corneal Edema in New York Corneal Edema in Los Angeles Corneal Edema in Chicago Corneal Edema in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease